Nym is a technology company.
Nym has raised $89.0M across 3 funding rounds.
Nym has raised $89.0M in total across 3 funding rounds.
# Nym: A Technology Company Operating in Two Distinct Markets
Nym operates as two separate entities serving fundamentally different markets. Nym Health is an AI-powered medical coding automation company that reduces administrative burden for healthcare providers by automating the medical coding process, currently processing over 6 million charts annually across more than 300 US healthcare facilities[1]. Nym Technologies, by contrast, is a privacy-focused infrastructure company building decentralized network solutions, particularly NymVPN, designed to protect user privacy through advanced cryptographic techniques and a noise-generating mixnet architecture[2][3].
The two companies represent distinct value propositions: Nym Health solves revenue cycle management challenges in healthcare through AI automation, while Nym Technologies addresses digital privacy concerns through decentralized, trustless network infrastructure. This dual focus reflects different market opportunities—one in enterprise healthcare optimization, the other in consumer and enterprise privacy protection.
Nym Technologies was founded by Harry Halpin, PhD, who serves as CEO and co-founder[2]. Halpin brings significant academic credentials, having previously served as a senior research scientist at MIT where he led standardization efforts for the Web Cryptography API, and at Inria de Paris researching socio-technical systems and privacy[2]. The company is backed by over 10 years of academic research and maintains ongoing collaborations with privacy teams at leading European universities[3].
Nym Health operates with a different leadership structure, featuring Yaniv in R&D (formerly SVP R&D at Verbit.ai) and Aya Weinstein as Vice President of Product (previously VP of Product at Liquidity Group)[1]. The company has assembled an interdisciplinary team of physicians, computational linguists, mathematicians, engineers, and medical coders to develop its autonomous medical coding solution[1].
Nym Technologies operates at the intersection of two major tech trends: the growing demand for privacy-preserving infrastructure and the rise of decentralized networks. As surveillance concerns mount and regulatory frameworks like GDPR reshape data handling expectations, decentralized VPN and privacy solutions address a structural gap in the market—traditional VPN providers require trust in a central entity, while Nym's architecture makes logging technically impossible[3].
Nym Health, meanwhile, addresses the healthcare industry's ongoing struggle with administrative overhead. Medical coding remains labor-intensive and error-prone, creating significant revenue leakage for providers. AI automation in this space directly impacts healthcare economics and operational efficiency, positioning Nym Health within the broader healthcare digital transformation movement.
Both entities reflect broader ecosystem trends: healthcare toward AI-driven automation and efficiency, and technology infrastructure toward privacy-by-design principles.
Nym Technologies is positioned to benefit from accelerating privacy consciousness among both consumers and enterprises, particularly as regulatory pressure increases and data breaches become more frequent. The company's academic foundation and cryptographic rigor differentiate it from consumer-focused VPN competitors, potentially opening enterprise security applications beyond traditional VPN use cases.
Nym Health operates in a market with structural tailwinds—healthcare providers face persistent coding backlogs and revenue cycle pressures that automation directly alleviates. As the company scales beyond 300 facilities, it could become a standard tool in healthcare revenue cycle management, similar to how other healthcare automation platforms have achieved market penetration.
The dual-entity structure suggests Nym's founders are pursuing parallel opportunities in distinct markets rather than a unified corporate vision. Success for both will depend on execution: Nym Technologies must convert privacy advocacy into sustainable adoption, while Nym Health must demonstrate that its autonomous coding engine maintains accuracy and compliance at scale while delivering measurable ROI to healthcare providers.
Nym has raised $89.0M in total across 3 funding rounds.
Nym's investors include Addition, Bessemer Venture Partners, Curie.Bio, Ben Robbins, GV, Operator Partners, Arkitekt Ventures, August Capital, Boldstart Ventures, Boost VC, Founder Collective, Innovation Endeavors.
Nym has raised $89.0M across 3 funding rounds. Most recently, it raised $47.0M Venture Round in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $47.0M Venture Round | Addition, Bessemer Venture Partners, Curie.Bio, Ben Robbins, GV, Operator Partners | |
| Jul 1, 2021 | $25.0M Series A | Addition, Arkitekt Ventures, August Capital, Bessemer Venture Partners, Boldstart Ventures, Boost VC, Curie.Bio, Founder Collective, Ben Robbins, Innovation Endeavors, INT3, Lux Capital, Maverick Capital, Metanoia, Operator Partners, Revolution, Scalar Capital, SNR, SV Angel, Alice Zhang, Aravind Bharadwaj, Ashley Larson, Elliott Cohen, Howie Liu, Yair Weinberger, Yoav Amit | |
| Oct 1, 2020 | $17.0M Series A | Addition, Arkitekt Ventures, August Capital, Bessemer Venture Partners, Boldstart Ventures, Boost VC, Curie.Bio, Founder Collective, GV, Innovation Endeavors, INT3, Lux Capital, Maverick Capital, Metanoia, Operator Partners, Revolution, Scalar Capital, SNR, SV Angel, Alice Zhang, Aravind Bharadwaj, Ashley Larson, Elliott Cohen, Howie Liu, Yair Weinberger, Yoav Amit |